Panelist discusses how atopic dermatitis presentation varies by age and skin tone, emphasizing that it's a systemic condition with multiple comorbidities that can be prevented through early aggressive treatment.
Video content above is prompted by the following:
Atopic dermatitis presentation varies significantly based on patient age and skin tone, making accurate diagnosis crucial for effective treatment. In infants, the condition typically affects the cheeks and extensor surfaces, presenting as red, inflamed areas that may appear rosy. However, healthcare providers must recognize that erythema appears differently across skin tones - while Caucasian and Asian patients show classic redness, patients of color may present with purplish-gray, pinkish-brown, or hyperpigmented lesions that can lead to underestimation of disease severity. This diagnostic challenge emphasizes the importance of calibrating clinical assessment skills to recognize atopic dermatitis across diverse patient populations.
The hallmark symptoms of atopic dermatitis include intense itching (without which the diagnosis cannot be made), chronic dry skin, and inflammation that varies by disease stage. Acute presentations feature papular, vesicular lesions with oozing and crusting, while chronic cases develop lichenified, alligator-like skin texture particularly common in patients of color. The condition can affect any body area, but distribution patterns change with age: infants show facial and extensor involvement, adolescents develop flexural patterns affecting antecubital and popliteal fossae, and adults may experience isolated hand or ankle involvement, highlighting the importance of age-appropriate diagnostic expectations.
Understanding atopic dermatitis as a systemic condition reveals its connection to multiple comorbidities, making comprehensive patient assessment essential. Patients with atopic dermatitis face increased risks for type-2 inflammatory conditions including asthma, allergic rhinitis, food allergies, nasal polyps, and eosinophilic esophagitis, particularly those with early onset and strong family histories. Additionally, poorly controlled atopic dermatitis contributes to neuropsychiatric comorbidities such as depression, anxiety, ADHD, and increased suicide risk, along with higher rates of skin infections, reduced bone mineral density from corticosteroid use, and cardiovascular disease. Emerging evidence suggests that early, aggressive treatment may prevent or halt the development of these associated conditions, emphasizing the importance of comprehensive, proactive management approaches.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.